ABCL Buy Disclosure
Montalbano John S. · SEC Form 4 · Filed Aug 18, 2026
Buy
Calculated transaction value
$110.3K
Montalbano John S. Director
ABCL
Transaction date
Aug 18, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed same day
ABCL daily price context
Close on/before transaction
$11.12
Aug 18, 2026
Close before public filing
$11.2
Aug 17, 2026
Return since public filing
+17.37%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 10,000 shares @ $11.03
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001834423-26-000008
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$110.3K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Abcellera Biologics Inc. ABCL Current | Buy | Aug 18, 2026 | $110.3K |